Chihiro is Head of Venture Management and Business Development for Rx+ Business at Astellas, a Japan based pharmaceutical company with $12B revenue globally.
Chihiro is responsible for investment and partnership strategy in Astellas’ external innovation group for the Rx+ business, which aims to create novel healthcare solutions that leverage the expertise and knowledge of the biopharma industry while integrating digital health and bioelectronics technology. Through the Rx+ digital health fund, Chihiro has managed various strategic relationships ranging from co-investments in neuromodulation companies to adding value as a Board observer. She has also led multiple strategic business development deals including in a digital therapeutics startup as well as the acquisition of iota Biosciences, a bioelectronics company for which she was a Board observer and led research collaboration prior to the acquisition.
Chihiro's passion is managing cross-industry collaboration. With her experience facilitating innovation by connecting experts from different fields, she believes the future of innovation includes dissolved borders between industries. She is keen to find areas where healthcare can intersect with other fields.
Education, Personal, and Fellowship
Chihiro holds a BSc in Chemistry and an MSc in Biochemistry from Waseda University and an MBA from Tsukuba University. During her MBA program, she represented Tsukuba University at a CFA Institute Research Challenge hosted by the CFA Society of Japan.
Chihiro is a member of Class 26 and is mentored by Koichiro Nakamura, Founder and General Partner of Sozo Ventures and Class 12 Kauffman Fellow.